Active

ARQUENNES PHARMA

Switched

BE0442964356

Rechtspersoon Public limited company 1 establishment

Chaussée de Nivelles 141, 7181 Seneffe Detailhandel in farmaceutische producten

Active for

35 year, 8 months

Financials

Financial year 2025

Gross margin

€ 462,062

▼ 4% vs 2024

Profit

Growing

€ 132,377

▲ 9% vs 2024

Debts

Normal

€ 474,162

▼ 17% vs 2024

ARQUENNES PHARMA from Seneffe, company number BE0442964356, closed financial year 2025 with a result of € 132,377 after tax. For that financial year ARQUENNES PHARMA recorded a gross margin of € 462,062 and equity of € 238,406. Compared with financial year 2024, the result moved from € 121,830 to € 132,377. Profitable, and profit is growing. The buffer is growing. Debts are under control. The most recent annual accounts were filed with the National Bank of Belgium on August 31, 2026.

What happened at ARQUENNES PHARMA?

What happened at ARQUENNES PHARMA in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

  • New annual accounts for financial year 2025: profit of € 132,377 (▲ 9% vs 2024). filed late Source: NBB ↗
  • New establishment in Seneffe. KBO
  • Start of the company according to the CBE. KBO

In short

From € 69,233 profit in 2021 to € 132,377 profit in 2025.

Paid € 12,621 in corporate taxes since 2021.

Best year ever: 2025, with € 132,377 profit.

On average € 115,500 of value added per employee in 2025.

A new publication or filing at ARQUENNES PHARMA? We notify you, reason included.

Follow ARQUENNES PHARMA

Need more data?

History

Every financial year, as far back as the National Bank goes.

Buffer

How long does the company survive without income?

Credit limit

Indicative credit limit, computed from the real figures.

Alerts

New annual account: profit halved. New
Gazette: capital increase of 250k. New

News about who you follow, reason included.

Databakkes Pro · first month free

Then €29.99/mo excl. VAT, cancel monthly. No credit card to try; the AI assistant is not included, or only in a very limited form, during the trial month. Sign up now and you’ll be invited first.

Management

Nadine Demeulemeester
Anne Dejardin
ARQUENNES PHARMA

Behind ARQUENNES PHARMA are GFCS SCS, Nadine Demeulemeester, Anne Dejardin and EGUIMAX SCS. The same people are also behind ACLOT PHARMA.

See the full network in the app

Directors

According to the 2025 annual accounts

GFCS SCS

Director · represented by ALEXANDRE DEHAYE

Also active at: ACLOT PHARMA

Nadine Demeulemeester

Director

Also active at: ACLOT PHARMA

Anne Dejardin

Managing director

EGUIMAX SCS

Director · represented by Philippe Dehaye

Also active at: ACLOT PHARMA

Establishments

Establishment units

Physical locations of this company

Registered office

Chaussée de Nivelles 141 box 2

7181 Seneffe

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 1 companies are registered at this address.

Details

Company number
0442.964.356
VAT number
BE 0442.964.356
Registered office
Chaussée de Nivelles 141 bus 2, 7181 Seneffe
Names & denominations
ARQUENNES PHARMA
Enterprise type
Rechtspersoon
Legal form
Public limited company
Legal situation
Normale toestand
Start date
7 January 1991
Peppol
Active · Active since 29 Jun 2026
Activities · NACE

Detailhandel in farmaceutische producten

Apothekers

Frequently asked questions

What is the enterprise number of ARQUENNES PHARMA?
The enterprise number of ARQUENNES PHARMA is BE0442964356.
What is the address of ARQUENNES PHARMA?
The registered office of ARQUENNES PHARMA is located at Chaussée de Nivelles 141 box 2, 7181 Seneffe.
When was ARQUENNES PHARMA founded?
ARQUENNES PHARMA was founded on 7 January 1991.
What is the main activity of ARQUENNES PHARMA?
The main activity of ARQUENNES PHARMA is "Detailhandel in farmaceutische producten" (NACE code 47730).
Does ARQUENNES PHARMA have a website?
No website is currently known for ARQUENNES PHARMA.
How much profit did ARQUENNES PHARMA make in 2025?
ARQUENNES PHARMA posted a profit after taxes of € 132,377 in financial year 2025.
What is the revenue of ARQUENNES PHARMA?
As a small company, ARQUENNES PHARMA is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 462,062.
How many employees does ARQUENNES PHARMA have?
According to the 2025 annual accounts, ARQUENNES PHARMA has 4 full-time equivalents (FTE).
Where can I find the annual accounts of ARQUENNES PHARMA?
ARQUENNES PHARMA files its annual accounts with the Central Balance Sheet Office of the National Bank of Belgium. The key figures for recent financial years are available for free on this page.
Who are the directors of ARQUENNES PHARMA?
According to the 2025 annual accounts, the directors of ARQUENNES PHARMA are: GFCS SCS, Nadine Demeulemeester, Anne Dejardin, EGUIMAX SCS.
Who owns ARQUENNES PHARMA?
Behind ARQUENNES PHARMA are GFCS SCS, Nadine Demeulemeester, Anne Dejardin and EGUIMAX SCS. The same people are also behind ACLOT PHARMA.